Inventor · disambiguated record
Ying-Huey Huang
Also filed as: HUANG YING · HUANG YING-HUEY
16 granted patents·6 pending applications·52 citations·filing 2004–2024
90Inventor score
Files withNOVARTIS AG9TAIGEN BIOTECHNOLOGY CO LTD7SHANGHAI HAIHE PHARMACEUTICAL CO LTD2CHAN HO MAN1HAIHE BIOPHARMA CO LTD1
Top patents by PatentIndex Score
22 records- 0193US11207325B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2020·Granted Dec 28, 2021·3 cites·19 claims
- 0289US9580437B2Triazolopyrimidine compounds and uses thereofCHAN HO MAN·Filed 2015·Granted Feb 28, 2017·15 cites·20 claims
- 0387US8193206B2Pyrimidine compoundsYEN CHI-FENG·Filed 2008·Granted Jun 5, 2012·9 cites·15 claims
- 0481US10689378B2Triazolopyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 23, 2020·4 cites·18 claims
- 0581US10220036B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 5, 2019·3 cites·26 claims
- 0681US7589197B2Pyrimidine compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2006·Granted Sep 15, 2009·7 cites·8 claims
- 0780US8372849B2Heterocyclic compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Granted Feb 12, 2013·5 cites·10 claims
- 0879US10676479B2Imidazolepyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 9, 2020·2 cites·10 claims
- 0975US11931363B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2021·Granted Mar 19, 2024·0 cites·22 claims
- 1069US9375406B2Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptorTAIGEN BIOTECHNOLOGY CO LTD·Filed 2014·Granted Jun 28, 2016·1 cites·10 claims
- 1168US11548897B2Crystalline forms of a triazolopyrimidine compoundNOVARTIS AG·Filed 2021·Granted Jan 10, 2023·0 cites·4 claims
- 1265US2024216378A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1364US7399776B2Polyamine compounds for treating chemokine receptor mediated diseasesTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted Jul 15, 2008·3 cites·6 claims
- 1463US11091489B2Crystalline forms of a triazolopyrimidine compoundNOVARTIS AG·Filed 2017·Granted Aug 17, 2021·0 cites·11 claims
- 1562US2019142837A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1653US2005003405A1Treatment and diagnostics of cancerFiled 2004·Application pending·0 cites
- 1746US11465984B2Compound having ERK kinase inhibitory activity and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 11, 2022·0 cites·25 claims
- 1846US7504422B2Polyamine compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2007·Granted Mar 17, 2009·0 cites·33 claims
- 1946US2009214529A9Kinesin inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Application pending·0 cites
- 2041US2021261539A1Compound having bet inhibitory activity and preparation method and use thereforSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 2140US2006036093A1Pyrimidinone compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2005·Application pending·0 cites
- 2235US11661421B2Indolizine compounds, preparation method and use thereofHAIHE BIOPHARMA CO LTD·Filed 2019·Granted May 30, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Ying-Huey Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →